Latest News about FDA
Recent news which mentions FDA
EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year
December 11, 2023
Tickers
ALZN
From Benzinga
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
From Benzinga
CBD's Critical Moment: Coalition Pushes For FDA Oversight
December 07, 2023
From Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
December 07, 2023
Tickers
DARE
From Benzinga
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
From Benzinga
Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes
December 04, 2023
From Benzinga
Congressional Report Sheds Light On Hemp's Impact And Future Prospects Amid Farm Bill Renewal Talks
December 04, 2023
From Benzinga
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
December 04, 2023
Tickers
ETNB
From Benzinga
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
November 29, 2023
Tickers
VVOS
From Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study
November 28, 2023
Tickers
ALDX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.